Nothing Special   »   [go: up one dir, main page]

DK3517151T3 - Ekstrakorporal fjernelse af mikrovesikulære partikler - Google Patents

Ekstrakorporal fjernelse af mikrovesikulære partikler Download PDF

Info

Publication number
DK3517151T3
DK3517151T3 DK19161598.8T DK19161598T DK3517151T3 DK 3517151 T3 DK3517151 T3 DK 3517151T3 DK 19161598 T DK19161598 T DK 19161598T DK 3517151 T3 DK3517151 T3 DK 3517151T3
Authority
DK
Denmark
Prior art keywords
corporal
extra
removal
microvesicular particles
microvesicular
Prior art date
Application number
DK19161598.8T
Other languages
English (en)
Inventor
Thomas Ichim
Richard H Tullis
Original Assignee
Aethlon Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aethlon Medical Inc filed Critical Aethlon Medical Inc
Application granted granted Critical
Publication of DK3517151T3 publication Critical patent/DK3517151T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19161598.8T 2006-03-09 2007-03-09 Ekstrakorporal fjernelse af mikrovesikulære partikler DK3517151T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78094506P 2006-03-09 2006-03-09
EP07752778.6A EP1993600B1 (en) 2006-03-09 2007-03-09 Extracorporeal removal of microvesicular particles

Publications (1)

Publication Number Publication Date
DK3517151T3 true DK3517151T3 (da) 2021-07-12

Family

ID=38475607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19161598.8T DK3517151T3 (da) 2006-03-09 2007-03-09 Ekstrakorporal fjernelse af mikrovesikulære partikler

Country Status (6)

Country Link
US (4) US8288172B2 (da)
EP (2) EP1993600B1 (da)
CA (2) CA2644855C (da)
DK (1) DK3517151T3 (da)
ES (2) ES2880460T3 (da)
WO (1) WO2007103572A2 (da)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2516403C (en) * 2003-01-17 2014-08-12 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
DK3517151T3 (da) 2006-03-09 2021-07-12 Aethlon Medical Inc Ekstrakorporal fjernelse af mikrovesikulære partikler
EP2176665B1 (en) * 2007-08-16 2016-03-02 The Royal Institution for the Advancement of Learning / McGill University Tumor cell-derived microvesicles
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
WO2009086203A2 (en) * 2007-12-27 2009-07-09 Aethlon Medical, Inc. Method and apparatus for increasing contaminant clearance rates during extracorporeal fluid treatment
EP2604704B1 (en) * 2008-02-01 2018-10-03 The General Hospital Corporation Use of microvesicles in diagnosis and prognosis of brain tumor
US20110218512A1 (en) * 2008-06-03 2011-09-08 Aethlon Medical, Inc. Enhanced antiviral therapy methods and devices
US10545149B2 (en) 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
US9487837B2 (en) 2008-10-06 2016-11-08 Morehouse School Of Medicine Exosome-mediated diagnosis of hepatitis virus infections and diseases
CN102308004A (zh) 2008-10-30 2012-01-04 卡里斯生命科学卢森堡控股有限责任公司 评价rna图案的方法
JP2012508577A (ja) 2008-11-12 2012-04-12 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 表現型を決定するためのエキソソームの使用方法およびそのシステム
WO2010065765A2 (en) * 2008-12-04 2010-06-10 Aethlon Medical, Inc. Affinity capture of circulating biomarkers
WO2011031892A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
EP2475988B1 (en) 2009-09-09 2018-11-14 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
EP2591359B1 (en) * 2010-07-07 2017-03-01 Aethlon Medical Inc Methods for quantifying exosomes
US20120046231A1 (en) * 2010-08-23 2012-02-23 Andre Francis Palmer Composition and process for synthesizing polymerized human serum albumin for applications in transfusion medicine
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
US20130295574A1 (en) 2010-11-10 2013-11-07 Exosome Diagnostics, Inc. Method for Isolation of Nucleic Acid Containing Particles and Extraction of Nucleic Acids Therefrom
US20140079717A1 (en) * 2011-02-17 2014-03-20 Cornell University Compositions and Methods to Prevent Cell Transformation and Cancer Metastasis
EP2495025A1 (en) 2011-03-04 2012-09-05 Fresenius Medical Care Deutschland GmbH Filter for the removal of micro-vesicles from biological fluids, methods and devices using such a filter
CA3039234C (en) * 2011-05-11 2023-03-28 Exosome Diagnostics, Inc. Nucleic acid extraction from heterogeneous biological materials
US9549953B2 (en) * 2011-12-08 2017-01-24 Eliaz Therapeutics, Inc. Galectin-3 plasmapheresis therapy
KR101933621B1 (ko) 2012-09-28 2018-12-28 삼성전자주식회사 소포를 분리하기 위한 조성물, 키트 및 이를 이용하여 소포를 분리하는 방법
DE102012019088A1 (de) * 2012-09-28 2014-04-03 Orthogen Ag Antibakterielle Arzneimittelpräparate
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
ES2626754T3 (es) 2012-11-26 2017-07-25 Gambro Lundia Ab Dispositivo de adsorción que combina perlas y membranas de fibra hueca
EP2735359B1 (en) 2012-11-26 2017-02-08 Gambro Lundia AB Integrated device for liver support systems
EP2735326B1 (en) 2012-11-26 2017-03-08 Gambro Lundia AB Liver support system
WO2014159662A1 (en) 2013-03-13 2014-10-02 University Of Miami Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
WO2014140884A2 (en) * 2013-03-15 2014-09-18 Novelogics Biotechnology, Inc. Methods and devices for removal of immunosuppressive ligands
CA2922689A1 (en) 2013-08-28 2015-03-05 Caris Life Sciences Switzerland Holdings Gmbh Oligonucleotide probes and uses thereof
WO2015113699A1 (en) * 2014-01-30 2015-08-06 Fresenius Hemocare Italia Srl Filtering device
CN106030304B (zh) 2014-02-27 2018-02-06 得克萨斯大学体系董事会 用于分离外来体的方法和组合物
US20170165334A1 (en) * 2015-12-11 2017-06-15 Tianxin Wang Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
CA2979361A1 (en) 2015-03-09 2016-09-15 Caris Science, Inc. Method of preparing oligonucleotide libraries
EP3287137B1 (en) 2015-03-12 2021-05-05 Mitsui Chemicals, Inc. Method for disrupting exosomes, exosome disruption kit, and method for separating exosomes derived from normal cells
EP3314027A4 (en) 2015-06-29 2019-07-03 Caris Science, Inc. THERAPEUTIC OLIGONUCLEOTIDES
AU2016298317B2 (en) 2015-07-28 2021-02-18 Caris Science, Inc. Targeted oligonucleotides
EP3246703A1 (en) 2016-05-20 2017-11-22 Unicyte EV AG Method and kit for capturing extracellular vesicles (evs) on a solid surface
CN110049771A (zh) 2016-10-13 2019-07-23 Vbc控股有限责任公司 癌症干细胞的外泌体
WO2019014486A1 (en) 2017-07-12 2019-01-17 Exosome Diagnostics, Inc. METHODS FOR ISOLATING AND ENRICHING POPULATIONS OF EXTRACELLULAR VESICLES DERIVED FROM BIOFLUIDS, AND METHODS OF USE THEREOF
CA3084620C (en) 2017-09-18 2024-06-18 Santersus Sa Method and device for purification of blood from circulating cell free dna
KR20210015740A (ko) * 2017-09-20 2021-02-10 몰레큘러 스테서스코프, 인크. 조직 상태를 검출하기 위한 방법 및 시스템
WO2019136289A1 (en) 2018-01-05 2019-07-11 Path Ex, Inc. Device for the capture and removal of disease material from fluids
BR112020020083A2 (pt) * 2018-03-30 2021-01-05 Exosomics S.P.A Uso in vitro de fibras ocas, método in vitro para obtenção de sangue ou de um derivado de sangue e método in vitro para analisar o teor de vesículas extracelulares de um sangue ou amostra líquida derivada de sangue
JP7489974B2 (ja) * 2018-10-17 2024-05-24 イムトリクス セラピューティクス、インコーポレイテッド 血漿分子及び粒子の炭素への吸着及び結合
CN113543821A (zh) 2019-03-06 2021-10-22 甘布罗伦迪亚股份公司 包含碱性磷酸酶的血液处理装置
WO2020260949A2 (en) * 2019-06-27 2020-12-30 Bioimmunate Technologies Ltd. Devices, systems, and methods for removal of components from biological fluids
JP2023522621A (ja) 2020-04-14 2023-05-31 サイトソーベンツ・コーポレーション 免疫調整治療による免疫応答の改善と免疫麻痺の減少
US10881781B1 (en) 2020-04-29 2021-01-05 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
WO2021221636A1 (en) * 2020-04-29 2021-11-04 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
US11103628B1 (en) * 2020-04-29 2021-08-31 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
USD952157S1 (en) 2020-06-19 2022-05-17 Qualigen Inc. Whole blood treatment cartridge
JP2023544112A (ja) 2020-09-21 2023-10-20 ベルジアン ボリション エスアールエル 血液中の遊離ヌクレオソームのインラインモニタリングのための装置
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
CN116648272A (zh) 2020-10-01 2023-08-25 英谬免疫股份有限公司 减少配体渗漏
US11319520B1 (en) * 2021-09-21 2022-05-03 Upside Foods, Inc. Filter cake-based systems and methods for the cultivation of cells and cell biomass
WO2023126672A1 (en) 2021-12-27 2023-07-06 Santersus Ag Method and device for removal of circulating cell free dna
WO2023194465A1 (en) * 2022-04-06 2023-10-12 Grifols Worldwide Operations Limited Extracellular vesicle depleted blood fractions
WO2024072901A1 (en) * 2022-09-28 2024-04-04 Sigyn Therapeutics, Inc. System and methods to enhance chemotherapy delivery and reduce toxicity

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925152A (en) 1971-06-18 1975-12-09 Exploaterings Ab Tbf Virus separation
US4714556A (en) * 1981-06-29 1987-12-22 Ambrus Clara M Blood purification
US4787974A (en) 1981-06-29 1988-11-29 Ambrus Clara M Blood purification
US4708713A (en) * 1984-11-16 1987-11-24 Anisa Medical, Inc. Method and system for removing immunosuppressive components from the blood of mammals
US5782792A (en) * 1986-11-21 1998-07-21 Cypress Bioscience, Inc. Method for treatment of rheumatoid arthritis
US5041079A (en) 1987-12-04 1991-08-20 Kuraray Co., Ltd. Method for removing human immunodeficiency virus and/or its related compounds
US5567588A (en) * 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US5268275A (en) * 1991-05-08 1993-12-07 The University Of North Carolina At Chapel Hill Vitamin K-dependent carboxylase
US5861310A (en) * 1993-11-03 1999-01-19 Dana-Farber Cancer Institute Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
JP3615785B2 (ja) * 1994-04-28 2005-02-02 テルモ株式会社 Ｈｉｖ及びその関連物質除去材料
CA2215905A1 (en) 1995-03-20 1996-09-26 Sumitomo Electric Industries, Ltd. Monoclonal antibody reacting specifically with fas ligand and process for producing the same
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
ES2214865T3 (es) * 1998-06-24 2004-09-16 CHEN & CHEN, LLC Columna analitica multicapas.
US6528057B1 (en) * 1998-08-31 2003-03-04 Julian L. Ambrus Method for removal of HIV and other viruses from blood
US20040214783A1 (en) * 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US7572631B2 (en) * 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US6812023B1 (en) * 2000-04-27 2004-11-02 Anosys, Inc. Methods of producing membrane vesicles
ATE512982T1 (de) * 2001-08-17 2011-07-15 Exothera L L C Verfahren und zusammensetzung zum gezielten einbringen in exosome
CA2479021A1 (en) * 2002-03-14 2003-09-18 Anosys, Inc. Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
CA2516403C (en) 2003-01-17 2014-08-12 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
CA2453198A1 (en) 2004-01-07 2005-07-07 Wei-Ping Min Quantification and generation of immune suppressive exosomes
EP1720611B1 (de) * 2004-02-16 2010-05-19 ProteoSys AG Diagnostische marker für krebs
ES2393637T3 (es) * 2004-04-30 2012-12-26 Biopheresis Technologies, Inc. Método y sistema para retirar TNFR1, TNFR2, y IL2R soluble en pacientes
US8021847B2 (en) * 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
AU2005262319A1 (en) * 2004-07-01 2006-01-19 Orthogen Ag Immunosuppressive exosomes
JP4029298B2 (ja) * 2004-07-26 2008-01-09 大塚製薬株式会社 粘着性マイクロベシクルの除去方法
CA2578539A1 (en) 2004-07-30 2006-02-09 Hans-Werner Heinrich Appliances and methods for cell, bio-particle and molecule sorting
CA2504279A1 (en) * 2005-04-15 2006-10-15 University Of Saskatchewan Materials and method of modulating the immune response using t helper-antigen presenting cells
EP1888096B1 (en) * 2005-05-13 2017-12-27 The Feinstein Institute for Medical Research Milk fat globule epidermal growth factor-factor viii and sepsis
US20090148460A1 (en) * 2005-07-08 2009-06-11 Alain Delcayre Exosome ligands, their preparation and uses
WO2007047907A2 (en) * 2005-10-14 2007-04-26 The Regents Of The University Of Michigan Dek protein compositions and methods of using the same
US20070122415A1 (en) * 2005-11-29 2007-05-31 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compound and method for suppressing retroviral replication
DK3517151T3 (da) * 2006-03-09 2021-07-12 Aethlon Medical Inc Ekstrakorporal fjernelse af mikrovesikulære partikler
WO2008092153A2 (en) * 2007-01-26 2008-07-31 University Of Louisville Research Foundation, Inc. Modification of exosomal components for use as a vaccine
US20090104649A1 (en) * 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
CN101755208B (zh) * 2007-07-25 2014-05-07 路易斯维尔大学研究基金会公司 作为诊断标记物的外来体相关微rna
EP2234642B8 (en) * 2007-11-28 2017-11-01 IRX Therapeutics, Inc. Method of increasing immunological effect
EP2604704B1 (en) * 2008-02-01 2018-10-03 The General Hospital Corporation Use of microvesicles in diagnosis and prognosis of brain tumor
JP2012508577A (ja) * 2008-11-12 2012-04-12 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 表現型を決定するためのエキソソームの使用方法およびそのシステム
WO2010065765A2 (en) * 2008-12-04 2010-06-10 Aethlon Medical, Inc. Affinity capture of circulating biomarkers
KR20120037992A (ko) * 2009-07-16 2012-04-20 더 제너럴 하스피탈 코포레이션 핵산 분석
AU2010324594B2 (en) * 2009-11-30 2016-09-15 Caris Life Sciences Switzerland Holdings Gmbh Methods and systems for isolating, storing, and analyzing vesicles
JP5778185B2 (ja) * 2010-02-11 2015-09-16 カトリーケ・ウニベルシタイト・リユーベン リン脂質プロファイリング及びガン
EP2591359B1 (en) * 2010-07-07 2017-03-01 Aethlon Medical Inc Methods for quantifying exosomes

Also Published As

Publication number Publication date
US20140166578A1 (en) 2014-06-19
EP1993600B1 (en) 2019-04-24
US9707333B2 (en) 2017-07-18
EP3517151A1 (en) 2019-07-31
CA2644855A1 (en) 2007-09-13
EP1993600A4 (en) 2014-02-19
ES2880460T3 (es) 2021-11-24
CA3061952A1 (en) 2007-09-13
WO2007103572A2 (en) 2007-09-13
US9364601B2 (en) 2016-06-14
US20090304677A1 (en) 2009-12-10
CA3061952C (en) 2022-07-19
EP1993600A2 (en) 2008-11-26
US8288172B2 (en) 2012-10-16
US20130015118A1 (en) 2013-01-17
CA2644855C (en) 2019-11-19
EP3517151B1 (en) 2021-04-21
US20140161810A1 (en) 2014-06-12
ES2736726T3 (es) 2020-01-07
WO2007103572A3 (en) 2008-09-12

Similar Documents

Publication Publication Date Title
DK3517151T3 (da) Ekstrakorporal fjernelse af mikrovesikulære partikler
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
DE602007008139D1 (de) Trennverfahren
DK2700786T3 (da) Modifikation af overførselspassage
DK2144498T3 (da) Akustisk bortskræmning
ATE539628T1 (de) Filter
DK2069312T3 (da) Pyridazinonderivater
DK2097402T3 (da) Makrocykliske inhibitorer af hepatitis c-virus
ATE536213T1 (de) Keramikfilter
DK3208269T3 (da) Inhibitorer af c-fms-kinase
EP2200734A4 (en) REMOVAL OF AMMONIA FROM FLUIDS
DK2219469T3 (da) Modificering af enzymatisk disponerede proteiner
DE602008002009D1 (de) Elektrostatische Klammer
DE602007011436D1 (de) Lufttrennverfahren
DK1739093T3 (da) Separation af plasmaproteiner
DK2178900T3 (da) Oprensning af pegylerede polypeptider
NO20062207L (no) Elektrostatisk koalescer
DK2114147T3 (da) Reduktion af bivirkninger af tramadol
BRPI0819628A2 (pt) partículas anticorrosivas
DK1867900T3 (da) Adskillelseselement
DE602007010428D1 (de) Teilcheneingeschlossener nanoschalter
DK2097469T3 (da) Stabile laktidpartikler
DK2077913T3 (da) Fremgangsmåde til regenerering af filterhjælpemiddel
DK2190451T3 (da) Behandling af atherosklerose
DK2040837T3 (da) Fremgangsmåde til fjernelse af tungmetaller